Evidence map›Paper›PMID 35601543›Full record

ArticleFrontiers in chemistry2022

Unnatural Amino Acid: 4-Aminopyrazolonyl Amino Acid Comprising

Amarnath Bollu, Prajnanandan Giri, Nihar Ranjan Dalabehera, Asmita Rani Asmi, Nagendra K Sharma

Open access · goldAbstract read
In one paragraph

Article in Frontiers in chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Amarnath BolluNational Institute of Science Education and Research (NISER), Bhubaneswar, India.
Prajnanandan GiriNational Institute of Science Education and Research (NISER), Bhubaneswar, India.
Nihar Ranjan DalabeheraNational Institute of Science Education and Research (NISER), Bhubaneswar, India.
Asmita Rani AsmiNational Institute of Science Education and Research (NISER), Bhubaneswar, India.
Nagendra K SharmaNational Institute of Science Education and Research (NISER), Bhubaneswar, India.
National Institute of Science Education and Research · INHomi Bhabha National Institute · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ampyrone is an amino-functionalized heterocyclic pyrazolone derivative that possesses therapeutic values such as analgesic, anti-inflammatory, and antipyretics. The chemical structure of ampyrone exhibits excellent hydrogen bonding sites and is considered as the potential scaffold of supramolecular self-assembly. Recently, this molecule has been derived into unnatural amino acids such as aminopyrazolone amino acid and its peptides. This report describes that one of its amino acids,

Indexed as

aminopyrazolonyl amino acidampyronehybrid-β-peptidesorganogelationunnatural amino acid

Identifiers

PMID35601543
PMCPMC9117720
OpenAlexW4281845578

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.